A detailed history of Neo Ivy Capital Management transactions in Zoetis Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 202 shares of ZTS stock, worth $35,341. This represents 0.09% of its overall portfolio holdings.

Number of Shares
202
Holding current value
$35,341
% of portfolio
0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 23, 2024

BUY
$151.44 - $200.09 $30,590 - $40,418
202 New
202 $40,000
Q4 2022

Mar 24, 2023

BUY
$131.14 - $157.47 $239,199 - $287,225
1,824 New
1,824 $267,000
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $15,278 - $18,423
-98 Closed
0 $0
Q1 2021

Oct 07, 2021

BUY
$144.0 - $169.39 $14,112 - $16,600
98 New
98 $15,000
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $446,400 - $511,680
-3,840 Closed
0 $0
Q3 2019

Nov 21, 2019

BUY
$112.57 - $128.43 $432,268 - $493,171
3,840 New
3,840 $485,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.